Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Organizational Clinical Pathways

  • Chapter
  • First Online:
Ischemic Stroke

Part of the book series: Emergency Management in Neurology ((EMN))

  • 2770 Accesses

Abstract

All patients with stroke or suspected stroke benefit from integrated stroke care systems which are created following the recommendations in the guidelines of the American Heart Association (AHA)/American Stroke Association (ASA) [1]. These care systems include hospitals for treating acute stroke, which often offer telemedicine and teleradiology, comprehensive stroke units, emergency units, public agencies and government resources. The objectives are prevention of stroke, optimal use of emergency departments, treatment of acute and subacute stroke, rehabilitation and follow-up, as well as educational programmes. Randomized clinical trials have shown that patients treated in primary stroke centres have a better outcome than patients treated in facilities without a stroke unit and that the rate of thrombolysis is higher; thus in the AHA/ASA guidelines, the creation of primary stroke centres is recommended (Class I, Evidence Level B), pointing out that these centres must be certified by an external organization. They further recommend setting up a multidisciplinary “improvement and quality” commission for reviewing and monitoring quality indicators, such as quality of care, evidence-based practice and prognosis (Class I, Level of Evidence B), in order to identify any deficiencies and to arrange to have them corrected.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 37.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jauch EC, Saver JL, Adams HP et al (2013) Guidelines for the early management of patients with acute ischemic stroke. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870–947

    Article  PubMed  Google Scholar 

  2. Kennedy RL, Bluhmki E, Von Kummer R et al (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS and EPITHET trials. Lancet 375:1695–1703

    Article  Google Scholar 

  3. Saver JL, Fonarow JC, Smith EE et al (2013) Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 309(23):2480–2488

    Article  CAS  PubMed  Google Scholar 

  4. Wardlaw JM, Murray V, Berge E et al (2012) Recombinant Tissue Plasminogen Activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 379:2364–2372

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Josephson SA, Hills NK, Johnston SC (2006) NIH stroke scale reliability in ratings from a large sample of clinicians. Cerebrovasc Dis 22:389–395

    Article  PubMed  Google Scholar 

  6. Rost NS, Masrur S, Pervez MA et al (2009) Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Neurology 73:1957–1962

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Cucchiara BL, Jackson B, Weiner M et al (2007) Usefulness of checking platelet count before thrombolysis in acute ischemic stroke. Stroke 38:1639–1640

    Article  PubMed  Google Scholar 

  8. European Stroke Organization (ESO) Executive Committee, ESO Writing Committee (2008) Guidelines for management of ischaemic stroke and transient ischemic attack. Cerebrovasc Dis 25:457–507

    Article  Google Scholar 

  9. Stroke Prevention And Educational Awareness Diffusion (SPREAD). Ictus cerebrale: linee guida italiane di prevenzione e trattamento. VII edizione. Stesura del 14 marzo 2012.

    Google Scholar 

  10. Powers WJ, Derdeyn CP, Biller J et al (2015) 2015 AHA/ASA focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment. Stroke 46:3020–3035

    Article  CAS  PubMed  Google Scholar 

  11. Barber PA, Darby DG, Desmond PM et al (1999) Identification of major ischemic change: diffusion-weighted imaging versus computed tomography. Stroke 30(10):2059–2065

    Google Scholar 

  12. Larrue V, Von Kummer R, Del Zoppo G et al (1997) Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in European Cooperative Acute Stroke Study. Stroke 28:957–960

    Article  CAS  PubMed  Google Scholar 

  13. Patel SC, Levine SR, Tilley BC et al (2001) National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Lack of significance of early ischemic stroke on computed tomography in acute stroke. JAMA 286:2830–2838

    Article  CAS  PubMed  Google Scholar 

  14. Pexman JH, Barber PA, Hill MD et al (2001) Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR 22:1534–1542

    CAS  PubMed  Google Scholar 

  15. The National Institute of Neurological Disorders and Stroke rt-PA Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587

    Article  Google Scholar 

  16. Sandercock P, Wardlaw JM, Lindley RI et al (2012) The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomized controlled trial. Lancet Neurol 379:2352–2363

    Article  Google Scholar 

  17. Wardlaw JM, Murray V, Berge E et al (2014) Thrombolysis for acute ischemic stroke. Cochrane Database Syst Rev 7:CD000213

    Google Scholar 

  18. Emberson J, Lees KR, Lyden P et al. for the Stroke Thrombolysis Trialists’ Collaborative Group (2014) Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 384:1929–1935

    Google Scholar 

  19. Toni D, Mangiafico S, Agostoni E et al (2015) Intravenous thrombolysis and intra-arterial interventions in acute ischemic stroke: Italian Stroke Organisation (ISO)-SPREAD guidelines. Int J Stroke 10:1119–1129

    Article  PubMed  Google Scholar 

  20. Miedema I, Luijckx GJ, De Keyser J et al (2012) Thrombolytic therapy for ischaemic stroke in patients using warfarin: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 83:537–540

    Article  PubMed  Google Scholar 

  21. De Keyser I, Gdovinovà Z, Uyttenboogaart M et al (2007) Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations. Stroke 38:2612–2618

    Article  PubMed  Google Scholar 

  22. Smith EE, Abdullah AR, Petkovska I et al (2005) Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke 36:2497–2499

    Article  CAS  PubMed  Google Scholar 

  23. Tong DC (2012) Avoiding thrombolysis in patients with mild stroke: is it SMART? Stroke 43(3):625–626

    Article  PubMed  Google Scholar 

  24. Tassi R, Acampa M, Marotta G et al (2013) Systemic thrombolysis for stroke in pregnancy. Am J Emerg Med 31(2):448.e1–448.e3

    Article  Google Scholar 

  25. Hill MD, Lye T, Moss H et al (2003) Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology 60:1525–1527

    Article  CAS  PubMed  Google Scholar 

  26. Ciccone A, Motto C, Aritzu E et al (2000) Negative interaction of aspirin and streptokinase in acute ischemic stroke: further analysis of the Multicenter Acute Stroke Trial-Italy. Cerebrovasc Dis 10(1):61–64

    Article  CAS  PubMed  Google Scholar 

  27. Goyal M, Demchuk AM, Menon BK et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372:1019–1030

    Article  CAS  PubMed  Google Scholar 

  28. Jovin TG, Chamorro A, Cobo E et al (2015) Thrombectomy within 8 hours after symptom on onset in ischemic stroke. N Engl J Med 372:2296–2306

    Article  CAS  PubMed  Google Scholar 

  29. Fransen P, Berkhemer O, Lingsma H, Beumer D, van den Berg L, van Zwam W, van Oostenbrugge R, van der Lugt A, Majoie C, Dippel D, for the MR CLEAN Investigators (2016) Time to reperfusion and effect of intra-arterial treatment in the MR CLEAN Trial. JAMA Neurol 73(2):190–196

    Article  PubMed  Google Scholar 

  30. Prabahakaran S, Ruff I, Bernstein RA (2015) Acute stroke intervention: a systematic review. JAMA 313(14):1451–1462

    Article  Google Scholar 

  31. Okumura K, Ohya Y, Maehara A et al (2005) Effects of blood pressure levels on case fatality after acute stroke. J Hypertens 23:1217–1223

    Article  CAS  PubMed  Google Scholar 

  32. Leonardi-Bee J, Bath PM, Phillips SJ (2002) Blood pressure and clinical outcomes in international stroke trial. Stroke 33:1315–1320

    Article  PubMed  Google Scholar 

  33. Prasad K, Krishnan PR (2010) Fever is associated with doubling of odds of short term mortality in ischemic stroke: an updated meta-analysis. Acta Neurol Scand 122:404–408

    Article  PubMed  Google Scholar 

  34. Ntaios G, Dziedzic T, Michel P et al (2015) European Stroke Organization (ESO) guidelines for the management of temperature in patients with acute ischemic stroke. Int J Stroke 10(6):941–949

    Article  PubMed  Google Scholar 

  35. Bruno A, Levine SR, Frankel MR et al (2002) Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial. Neurology 59:669–674

    Article  CAS  PubMed  Google Scholar 

  36. Demchuk AM, Tanne D, Hill MD et al (2001) Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology 57:474–480

    Article  CAS  PubMed  Google Scholar 

  37. Bellolio MF, Gilmore RM, Ganti L (2014) Insulin for Glycaemic control in acute ischaemic stroke. Cochrane Database Syst Rev 9:CD005346

    Google Scholar 

  38. American Diabetes Association (2010) Standard of medical care in diabetes. Diabetes Care 33:692

    Article  Google Scholar 

  39. Coull AJ, Lovett JK, Rothwell PM et al (2004) Population based study of early risk of stroke after transient ischemic attack or minor stroke: implication for public education and organization of services. BMJ 328(7435):326

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Redgrave JN, Coutts SB, Schulz UG et al (2007) Systematic review of association between the presence of acute ischemic lesion on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. Stroke 38:1482–1488

    Article  PubMed  Google Scholar 

  41. Vahedi K, Hofmeijer J, Juettler E et al (2007) Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomized controlled trials. Lancet Neurol 6:215–222

    Article  PubMed  Google Scholar 

  42. Qureshy AI, Suarez JI, Yahia AM et al (2003) Timing of neurological deterioration in massive middle cerebral artery infarction: a multicenter review. Crit Care Med 31:272–277

    Article  Google Scholar 

  43. Hacke W, Schwab S, Horn M (1996) “Malignant” middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 53:309–315

    Article  CAS  PubMed  Google Scholar 

  44. Westendorp WF, Vermeij JD, Zock E et al. for the PASS investigators (2015) The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomized open-label masked endpoint clinical trial. Lancet 385:1519–1526

    Google Scholar 

  45. Chen HJ, Lee TC, Wei CP (1992) Treatment of cerebellar infarction by decompressive suboccipital craniectomy. Stroke 23:957–961

    Article  CAS  PubMed  Google Scholar 

  46. Leigh R, Zaidat OO, Suri MF et al (2004) Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke 35:1903–1907

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology and Stroke Unit, Department of Neuroscience, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

    Valentina Oppo MD & Valentina Perini MD

  2. Department of Neuroscience, Department of Neurology and Stroke Unit, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

    Cristina Motto MD

Authors
  1. Valentina Oppo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cristina Motto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Valentina Perini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Valentina Perini MD .

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Oppo, V., Motto, C., Perini, V. (2017). Organizational Clinical Pathways. In: Ischemic Stroke. Emergency Management in Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-31705-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31705-2_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31704-5

  • Online ISBN: 978-3-319-31705-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation